Temperature-driven premature ageing of cellular populations in energy-storing tendons: the gap junction connection.

温度驱动的能量储存肌腱中细胞群的过早老化:间隙连接连接。

基本信息

  • 批准号:
    BB/J000655/1
  • 负责人:
  • 金额:
    $ 19.72万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2012
  • 资助国家:
    英国
  • 起止时间:
    2012 至 无数据
  • 项目状态:
    已结题

项目摘要

Athletes who participate in running and jumping have a similar problem to their equine counterparts on the racetrack. Both frequently injure large tendons in their legs that function as 'biological springs' to save muscular effort by stretching and storing energy when the leg bears weight, then rebounding to propel the athlete forward. In people the Achilles tendon (AT) has this function, while in horses it is the superficial digital flexor tendon (SDFT). As more people participate in sports to improve their health and maintain mobility during ageing, more AT injuries are occurring. In Scotland the incidence has increased by 90% over the last 15 years, now comprising >10% of soft tissue injuries. Up to 30% of racehorses suffer similar problems. Tendons heal slowly with scar tissue and never regain their original strength. Such injuries interrupted the international careers of David Beckham and Kelly Holmes, and those of many well-known racehorses including Kicking King, the 2005 Cheltenham Cup winner. Tendon injuries follow an undefined period of accumulation of painless damage to their substance (matrix) during exercise. Tendon cells, called tenocytes, do not repair this 'microdamage' and may be killed, begin to produce the wrong type of collagen, and/or degrade the surrounding matrix, causing a vicious injury cycle. Research over many years has suggested that this degeneration represents acceleration of a normally age-related process. Slowing or preventing this would have a greater impact on preventing injuries, and so improving performance and welfare of athletes than attempting treatment. We think a major factor causing tenocyte injury is high temperature. As tendons stretch and contract, some stored energy is lost as heat that cannot be easily dissipated. The SDFT core reaches at least 45oC during galloping, from its normal temperature of 37-38oC. As the AT functions in a similar way, hyperthermia is also highly likely to occur in its core. In the laboratory, most tenocytes die after 10 min at 45oC, but interestingly this involves transmission of 'death signals' between cells through gap junctions (GJ). GJ are small pores directly connecting neighbouring cells into networks. When GJ are chemically blocked following heating much of the tenocyte death and upregulation of less effective matrix proteins can be prevented. This is exciting, as GJ can be manipulated. We will use cells and tissue from SDFTs to determine when, relative to heating, the tenocytes 'decide' to die or alter their activity. We will measure an array of biomarkers to identify points at which we might reverse these changes e.g. do we need to do something within minutes or hours? Secondly we will explore a drug-free method of intervention: cooling of tendons after exercise e.g. using ice baths is often used as an 'injury prevention' measure. Cooling can close GJ in other cell types, which could prevent spread of death signals during critical post-exercise periods. Mild hypothermia (i.e. 32oC) may also upregulate 'cold-stress proteins' that protect cells. We aim to understand when, for how long, at what levels and how many times temperature differentials should be applied by athletes to reduce tendon microdamage. In the final part of this project we will look at one of the major proteins making up the GJ, called connexin 43 (Cx43). We will investigate methods of targeting the Cx43 molecule i.e. preventing it from being made within tenocytes. This will allow us to better understand how GJ influence cell death/damage following heat shock, but may also facilitate development of drugs to regulate it that could be delivered locally e.g. in gels or ointments. With the upcoming London Olympic Games and Glasgow Commonwealth Games and the likelihood that increasing numbers of people will be inspired to participate in athletic activity, this is a timely opportunity to develop methods of preventing injuries while also improving the welfare of horses.
参加跑步和跳跃的运动员与赛马场上的马有类似的问题。两人都经常损伤腿部的大肌腱,这些肌腱作为“生物弹簧”,在腿部承重时通过拉伸和储存能量来节省肌肉的力量,然后反弹推动运动员前进。人类的跟腱(AT)具有这种功能,而马的跟腱是指浅屈肌腱(SDFT)。随着越来越多的人参加体育运动以改善健康状况并在衰老期间保持活动能力,越来越多的AT损伤正在发生。在苏格兰,发病率在过去15年中增加了90%,现在占软组织损伤的10%以上。多达30%的赛马遭受类似的问题。肌腱愈合缓慢,疤痕组织,永远不会恢复原来的力量。此类伤病中断了大卫·贝克汉姆和凯莉·霍姆斯的国际职业生涯,以及许多知名赛马的职业生涯,其中包括2005年切尔滕纳姆杯冠军踢球王。肌腱损伤是在运动过程中对其物质(基质)的无痛性损伤积累的一段不确定的时期。肌腱细胞,称为腱细胞,不修复这种“微损伤”,可能会被杀死,开始产生错误类型的胶原蛋白,和/或降解周围的基质,导致恶性损伤循环。多年来的研究表明,这种退化代表了一个正常的与年龄有关的过程的加速。减缓或防止这种情况发生将对预防受伤产生更大的影响,从而提高运动员的表现和福利,而不是试图治疗。我们认为导致肌腱细胞损伤的一个主要因素是高温。当肌腱伸展和收缩时,一些储存的能量会以热量的形式损失,而这些热量不容易消散。SDFT核心在舞动期间至少达到45摄氏度,而正常温度为37- 38摄氏度。由于AT以类似的方式发挥作用,因此其核心也极有可能发生高热。在实验室中,大多数肌腱细胞在45 ℃下10分钟后死亡,但有趣的是,这涉及通过间隙连接(GJ)在细胞之间传递“死亡信号”。GJ是直接将相邻细胞连接成网络的小孔。当GJ在加热后被化学阻断时,可以防止大部分腱细胞死亡和不太有效的基质蛋白的上调。这是令人兴奋的,因为GJ可以被操纵。我们将使用来自SDFT的细胞和组织来确定相对于加热,腱细胞何时“决定”死亡或改变其活性。我们将测量一系列生物标志物,以确定我们可能逆转这些变化的点,例如我们需要在几分钟或几小时内做些什么?其次,我们将探索一种无药物的干预方法:运动后冷却肌腱,例如使用冰浴通常被用作“预防伤害”的措施。冷却可以关闭其他细胞类型的GJ,这可以防止运动后关键时期死亡信号的传播。轻度低温(即32 ℃)也可能上调保护细胞的“冷应激蛋白”。我们的目标是了解运动员应该在什么时候,多长时间,在什么水平和多少次温差下应用,以减少肌腱微损伤。在这个项目的最后一部分,我们将研究组成GJ的主要蛋白质之一,称为连接蛋白43(Cx43)。我们将研究靶向Cx43分子的方法,即防止其在腱细胞内产生。这将使我们能够更好地了解GJ如何影响热休克后的细胞死亡/损伤,但也可能促进药物的开发,以调节它可以在局部,例如在凝胶或软膏中递送。随着即将到来的伦敦奥运会和格拉斯哥英联邦运动会以及越来越多的人将受到启发参加体育活动的可能性,这是一个及时的机会,以制定预防受伤的方法,同时也提高了马匹的福利。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Science-in-brief: What is needed to prevent tendon injury in equine athletes? A conversation between researchers and industry stakeholders.
科学简述:预防马运动员肌腱损伤需要什么?
  • DOI:
    10.1111/evj.12269
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Rich T
  • 通讯作者:
    Rich T
Indicators of replicative damage in equine tendon fibroblast monolayers.
马腱成纤维细胞单层复制损伤的指标。
  • DOI:
    10.1186/1746-6148-9-180
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Rich T
  • 通讯作者:
    Rich T
Exposure of a tendon extracellular matrix to synovial fluid triggers endogenous and engrafted cell death: A mechanism for failed healing of intrathecal tendon injuries
  • DOI:
    10.1080/03008207.2016.1245726
  • 发表时间:
    2017-01-01
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Garvican, Elaine R.;Salavati, Mazdak;Dudhia, Jayesh
  • 通讯作者:
    Dudhia, Jayesh
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tina Rich其他文献

Defying death after DNA damage
在 DNA 损伤后抵御死亡
  • DOI:
    10.1038/35037717
  • 发表时间:
    2000-10-12
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Tina Rich;Rachel L. Allen;Andrew H. Wyllie
  • 通讯作者:
    Andrew H. Wyllie
Evidence for the receipt of DNA damage stimuli by PML nuclear domains
PML 核结构域接收 DNA 损伤刺激的证据
  • DOI:
    10.1002/path.2126
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Archana Varadaraj;Claire L. Dovey;L. Laredj;Brian J. Ferguson;Clare E. Alexander;N. Lubben;Andrew H. Wyllie;Tina Rich
  • 通讯作者:
    Tina Rich
オリゴデンドログリオーマ細胞の形態と分化
少突胶质细胞瘤细胞的形态和分化
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hong Luo;Keiko Takahashi;Yun-Long Qi;Mami Terao;Miho Hoshino;Mikio Hoshino;Tina Rich;and Hitoshi Okazawa;中里洋一
  • 通讯作者:
    中里洋一
Functional deficiency of PQBP1 impairs cell cycle progression of neural stem cells through a splicing factor U5-15kD
PQBP1 功能缺陷通过剪接因子 U5-15kD 损害神经干细胞的细胞周期进程
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hong Luo;Keiko Takahashi;Yun-Long Qi;Mami Terao;Miho Hoshino;Mikio Hoshino;Tina Rich;and Hitoshi Okazawa
  • 通讯作者:
    and Hitoshi Okazawa
cDNA cloning, tissue distribution and chromosomal localization of the human ID4 gene.
人类 ID4 基因的 cDNA 克隆、组织分布和染色体定位。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Muriel Rigolet;Tina Rich;Marie;Denise MOLINA;Evani VIEGAS;Claudine Junien
  • 通讯作者:
    Claudine Junien

Tina Rich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tina Rich', 18)}}的其他基金

EU-Canada Workshop on Preventing Tendon Injury in Equine Athletes: Translation of Accurate In Vitro Modelling to the Racetrack
欧盟-加拿大预防马运动员肌腱损伤研讨会:将准确的体外模型转化为赛马场
  • 批准号:
    BB/K021192/1
  • 财政年份:
    2013
  • 资助金额:
    $ 19.72万
  • 项目类别:
    Research Grant

相似国自然基金

Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国青年学者研究基金项目
基于Cache的远程计时攻击研究
  • 批准号:
    60772082
  • 批准年份:
    2007
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

The role of stress, social support, and brain function on alcohol misuse in women
压力、社会支持和大脑功能对女性酗酒的影响
  • 批准号:
    10676428
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Gestationally driven trafficking of decidual lymphocytes assessed by serial intravascular staining
通过连续血管内染色评估妊娠驱动的蜕膜淋巴细胞运输
  • 批准号:
    10645445
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Transfusion-driven hyperhemolysis in sickle cell disease
镰状细胞病中输血引起的高溶血症
  • 批准号:
    10668756
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Multiomics and Functional Characterization Establish Druggable Targets for PVC-Driven Idiopathic VF
多组学和功能表征为 PVC 驱动的特发性心室颤动建立药物靶标
  • 批准号:
    10750784
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Community-Driven Indigenous Research, Cultural Strengths & Leadership to Advance Equity in Drug Use Outcomes (CIRCLE)
社区驱动的本土研究、文化优势
  • 批准号:
    10713129
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Pharmacodynamic Biomarker of Myotonic Dystrophy
强直性肌营养不良的药效生物标志物
  • 批准号:
    10651049
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Transfusion-driven hyperhemolysis in sickle cell disease
镰状细胞病中输血引起的高溶血症
  • 批准号:
    10690278
  • 财政年份:
    2022
  • 资助金额:
    $ 19.72万
  • 项目类别:
A self-capacitance driven wearable electromyometrial imaging system for maternal and fetal monitoring during pregnancy and labor
一种自电容驱动的可穿戴式肌电成像系统,用于妊娠和分娩期间的母婴监测
  • 批准号:
    10666402
  • 财政年份:
    2022
  • 资助金额:
    $ 19.72万
  • 项目类别:
Environmentally-responsive, dual-stage microparticle drug depots with healing-driven growth factor delivery for craniofacial bone regeneration
环境响应型双级微粒药物库,具有愈合驱动的生长因子输送,用于颅面骨再生
  • 批准号:
    10527614
  • 财政年份:
    2022
  • 资助金额:
    $ 19.72万
  • 项目类别:
A self-capacitance driven wearable electromyometrial imaging system for maternal and fetal monitoring during pregnancy and labor
一种自电容驱动的可穿戴式肌电成像系统,用于妊娠和分娩期间的母婴监测
  • 批准号:
    10445605
  • 财政年份:
    2022
  • 资助金额:
    $ 19.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了